Clorox (NYSE:CLX) Releases FY 2026 Earnings Guidance

Key Points

• Clorox has provided an update to its FY 2026 earnings guidance, projecting earnings per share between 5.950 and 6.30, which is below the consensus estimate of 6.715.
• The company recently declared a quarterly dividend increase to $1.24, representing an annualized yield of 4.0% and a payout ratio of 87.61%.
• Multiple analysts have downgraded their price targets for Clorox, with Barclays reducing it from $129.00 to $119.00 and Wells Fargo from $142.00 to $135.00.

Clorox (NYSE:CLX - Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 5.950-6.30 for the period, compared to the consensus earnings per share estimate of 6.715. The company issued revenue guidance of -.

Clorox Trading Up 1.4%

Shares of NYSE CLX traded up $1.75 during mid-day trading on Monday, hitting $124.85. The company's stock had a trading volume of 297,500 shares, compared to its average volume of 1,627,012. The stock has a market cap of $15.39 billion, a price-to-earnings ratio of 19.12, a price-to-earnings-growth ratio of 3.64 and a beta of 0.49. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. Clorox has a one year low of $117.35 and a one year high of $171.37. The company's fifty day simple moving average is $126.07 and its 200-day simple moving average is $138.86.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company's revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.82 EPS. On average, sell-side analysts anticipate that Clorox will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Wednesday, August 13th will be given a $1.24 dividend. The ex-dividend date is Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. This is a positive change from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is 74.85%.

Analyst Ratings Changes

CLX has been the topic of a number of analyst reports. Jefferies Financial Group cut their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. JPMorgan Chase & Co. cut their price target on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Barclays cut their price target on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research report on Tuesday, July 15th. Wells Fargo & Company raised their target price on shares of Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a report on Friday. Finally, Citigroup restated a "neutral" rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Clorox presently has a consensus rating of "Hold" and a consensus target price of $143.36.

Insider Buying and Selling

In related news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, with a total value of $546,280.00. Following the transaction, the director owned 4,000 shares of the company's stock, valued at $546,280. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.57% of the company's stock.

Institutional Investors Weigh In On Clorox

An institutional investor recently raised its position in Clorox stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 4.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,380 shares of the company's stock after purchasing an additional 514 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Clorox were worth $1,970,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.